España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
PepGen
PEPG
NASDAQ
Watchlist
Get Report
Perks
Buy
Compare Brokers
$16.68
0.36
2.21%
At Close: -
$16.32
-0.36
-2.16%
After Hours: Jul 2, 4:02 PM EDT
15 minutes delayed
Get Report
Watch
PepGen (PEPG) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for PepGen (NASDAQ:PEPG) Stock
PepGen Stock (NASDAQ: PEPG)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, June 28, 2024
PepGen Files $250M Mixed Securities Shelf
Benzinga Newsdesk
Wednesday, May 15, 2024
HC Wainwright & Co. Reiterates Buy on PepGen,...
Benzinga Newsdesk
Wedbush Reiterates Outperform on PepGen, Main...
Benzinga Newsdesk
Tuesday, May 14, 2024
CORRECTION: PepGen Q1 2024 GAAP EPS $(0.63) B...
Benzinga Newsdesk
Friday, April 12, 2024
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Wednesday, April 10, 2024
Insiders Buying GameStop And 2 Other Stocks
Avi Kapoor
Wednesday, March 13, 2024
PepGen Receives U.S. FDA Orphan Drug And Rare...
Benzinga Newsdesk
Thursday, March 07, 2024
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
PepGen shares are trading lower after the com...
Benzinga Newsdesk
PepGen Reported March 6 Q4 2023 GAAP EPS $(0....
Benzinga Newsdesk
Wedbush Maintains Outperform on PepGen, Lower...
Benzinga Newsdesk
Monday, March 04, 2024
PepGen Announces Clearance of CTA by UK Medic...
Benzinga Newsdesk
Tuesday, February 20, 2024
PepGen Receives FDA Fast Track Designation Fo...
Benzinga Newsdesk
Wednesday, February 14, 2024
Over $37M Bet On This Industrial Stock? Check Out These 4 Stocks Insiders Are Buying
Avi Kapoor
Wednesday, February 07, 2024
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
PepGen Reports Pricing Of Offering Of 7.53M S...
Benzinga Newsdesk
Friday, February 02, 2024
Top 4 Health Care Stocks That May Crash This Quarter
Avi Kapoor
Tuesday, January 30, 2024
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Wedbush Reiterates Outperform on PepGen, Main...
Benzinga Newsdesk
Monday, January 08, 2024
PepGen Announced First Patient Dosed in CONNECT1-EDO51 Phase 2 Clinical Trial of PGN-EDO51 for Duchenne Muscular Dystrophy Patients Amenable to Exon 51 Skipping
Charles Gross
Monday, December 18, 2023
PepGen Announces First Patient Dosed In Phase...
Benzinga Newsdesk
Wednesday, November 15, 2023
Board Member at PepGen Acquires Company Stock Options Worth 22,686 Shares
Benzinga Insights
Wednesday, November 08, 2023
PepGen: Q3 Earnings Insights
Benzinga Insights
PepGen Q3 EPS $(0.98) Misses $(0.88) Estimate...
Benzinga Newsdesk
Thursday, October 12, 2023
The FDA Has Lifted The Full Clinical Hold And...
Benzinga Newsdesk
Thursday, September 07, 2023
HC Wainwright & Co. Reiterates Buy on PepGen,...
Benzinga Newsdesk
Wednesday, September 06, 2023
PepGen Inc. Announces Clearance Of CTA By Hea...
Benzinga Newsdesk
PepGen Announced Key Highlights From The Upco...
Benzinga Newsdesk
Wednesday, August 09, 2023
HC Wainwright & Co. Reiterates Buy on PepGen,...
Benzinga Newsdesk
Tuesday, August 08, 2023
PepGen Q2 EPS $(0.82) Misses $(0.81) Estimate
Benzinga Newsdesk
Tuesday, June 27, 2023
PepGen Director Awarded $85K Worth of Stock Options
Benzinga Insights
Board Member at PepGen Acquires Company Stock Options Worth 12,000 Shares
Benzinga Insights
Director at PepGen Acquires Company Stock Options Worth 12,000 Shares
Benzinga Insights
PepGen Director Awarded $114K Worth of Stock Options
Benzinga Insights
Wednesday, June 14, 2023
The Latest Analyst Ratings for PepGen
Benzinga Insights
Stifel Reiterates Buy on PepGen, Maintains $2...
Benzinga Newsdesk
Wedbush Reiterates Outperform on PepGen, Main...
Benzinga Newsdesk
Tuesday, June 13, 2023
PepGen Withdraws Prior Guidance With Respect ...
Benzinga Newsdesk
Friday, June 09, 2023
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Why American Software Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Lisa Levin
Monday, June 05, 2023
SAIC, HealthEquity And 3 Stocks To Watch Heading Into Monday
Lisa Levin
Friday, June 02, 2023
PepGen Inc Files For Mixed Shelf Of Up To $30...
Benzinga Newsdesk
Wednesday, May 31, 2023
Wedbush Reiterates Outperform on PepGen, Main...
Benzinga Newsdesk
Tuesday, May 30, 2023
PepGen Inc. Announces Clinical Hold In The US...
Benzinga Newsdesk
Friday, May 12, 2023
HC Wainwright & Co. Reiterates Buy on PepGen,...
Benzinga Newsdesk
Thursday, May 11, 2023
PepGen: Q1 Earnings Insights
Benzinga Insights
PepGen Q1 EPS $(0.69) Beats $(0.79) Estimate;...
Benzinga Newsdesk
Monday, April 03, 2023
HC Wainwright & Co. Reiterates Buy on PepGen,...
Benzinga Newsdesk
Monday, March 27, 2023
Why Jounce Therapeutics Shares Are Trading Higher By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
